Investing.com - Aptevo Therapeutics reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Aptevo Therapeutics announced earnings per share of $-1.50 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.35 on revenue of $1.85M.
Aptevo Therapeutics shares are up 25.4% from the beginning of the year and are trading at $2.89 , down-from-52-week-high.
Aptevo Therapeutics follows other major Healthcare sector earnings this month
Aptevo Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar